A Phase 1/2 Study of SY-12321 in Patients With ALK-positive Advanced Malignancies

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Phase 1/2 Study of SY-12321 in Patients With ALK-positive Advanced Malignancies	ALK Positive Advanced Malignancies	Recruiting	Phase 1 / Phase 2	2026-09-09		NCT07810933

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Shouyao Holdings (Beijing) Co. LTD	5

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Sun Yat-Sen University Cancer Center	Guangzhou	China	113
The Affiliated Hospital of Nanjing University Medical School	Nanjing	China	1

Clinical trials